HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of delayed rectifier potassium channels and induction of arrhythmia: a novel effect of celecoxib and the mechanism underlying it.

Abstract
Selective inhibitors of cyclooxygenase-2 (COX-2), such as rofecoxib (Vioxx), celecoxib (Celebrex), and valdecoxib (Bextra), have been developed for treating arthritis and other musculoskeletal complaints. Selective inhibition of COX-2 over COX-1 results in preferential decrease in prostacyclin production over thromboxane A2 production, thus leading to less gastric effects than those seen with nonselective COX inhibitors such as acetylsalicylic acid (aspirin). Here we show a novel effect of celecoxib via a mechanism that is independent of COX-2 inhibition. The drug inhibited the delayed rectifier (Kv2) potassium channels from Drosophila, rats, and humans and led to pronounced arrhythmia in Drosophila heart and arrhythmic beating of rat heart cells in culture. These effects occurred despite the genomic absence of cyclooxygenases in Drosophila and the failure of acetylsalicylic acid, a potent inhibitor of both COX-1 and COX-2, to inhibit rat Kv2.1 channels. A genetically null mutant of Drosophila Shab (Kv2) channels reproduced the cardiac effect of celecoxib, and the drug was unable to further enhance the effect of the mutation. These observations reveal an unanticipated effect of celecoxib on Drosophila hearts and on heart cells from rats, implicating the inhibition of Kv2 channels as the mechanism underlying this effect.
AuthorsRoman V Frolov, Ilya G Berim, Satpal Singh
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 283 Issue 3 Pg. 1518-1524 (Jan 18 2008) ISSN: 0021-9258 [Print] United States
PMID17984087 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Cyclooxygenase Inhibitors
  • Delayed Rectifier Potassium Channels
  • Pyrazoles
  • Shab Potassium Channels
  • Sulfonamides
  • Celecoxib
Topics
  • Animals
  • Arrhythmias, Cardiac (chemically induced)
  • Celecoxib
  • Cells, Cultured
  • Cyclooxygenase Inhibitors (pharmacology)
  • Delayed Rectifier Potassium Channels (antagonists & inhibitors)
  • Drosophila melanogaster (drug effects, metabolism)
  • Heart Rate (drug effects)
  • Humans
  • Models, Biological
  • Myocytes, Cardiac (drug effects, metabolism)
  • Pyrazoles (pharmacology)
  • Rats
  • Shab Potassium Channels (metabolism)
  • Sulfonamides (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: